POLYETHYLENE GLYCOL 3350

POLYETHYLENE GLYCOL 3350 was reported 96561 times

These side effects are most commonly reported by patients taking POLYETHYLENE GLYCOL 3350:

# Side effect Count
0 DRUG INEFFECTIVE 10049
1 PRODUCT USE ISSUE 10036
2 OFF LABEL USE 9245
3 DIARRHOEA 7279
4 NAUSEA 5621
5 CONSTIPATION 5484
6 FATIGUE 4910
7 PRODUCT USE IN UNAPPROVED INDICATION 3776
8 VOMITING 3486
9 PAIN 3086
10 DEATH 2916
11 DYSPNOEA 2891
12 HEADACHE 2875
13 INCORRECT DOSE ADMINISTERED 2858
14 INCORRECT DRUG ADMINISTRATION DURATION 2837
15 ASTHENIA 2791
16 DIZZINESS 2625
17 ABDOMINAL PAIN 2566
18 FALL 2422
19 INCORRECT PRODUCT ADMINISTRATION DURATION 2362
20 ABDOMINAL DISTENSION 2340
21 ABDOMINAL PAIN UPPER 2278
22 PNEUMONIA 2230
23 WEIGHT DECREASED 2183
24 PRODUCT PRESCRIBING ISSUE 2021
25 MALAISE 2001
26 FLATULENCE 1998
27 PYREXIA 1945
28 UNDERDOSE 1822
29 DECREASED APPETITE 1819
30 RASH 1787
31 EXPIRED PRODUCT ADMINISTERED 1784
32 URINARY TRACT INFECTION 1720
33 ANXIETY 1638
34 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1605
35 ARTHRALGIA 1591
36 BACK PAIN 1556
37 COUGH 1529
38 ANAEMIA 1519
39 INSOMNIA 1505
40 DEHYDRATION 1488
41 ABDOMINAL DISCOMFORT 1457
42 MUSCLE SPASMS 1456
43 PAIN IN EXTREMITY 1436
44 PRURITUS 1416
45 CONDITION AGGRAVATED 1398
46 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1379
47 HYPOTENSION 1285
48 SOMNOLENCE 1276
49 DEPRESSION 1242
50 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1224
51 FEELING ABNORMAL 1210
52 PRODUCT DOSE OMISSION ISSUE 1201
53 CONFUSIONAL STATE 1162
54 HYPERTENSION 1123
55 CHEST PAIN 1109
56 TREMOR 1098
57 GAIT DISTURBANCE 1096
58 OVERDOSE 1095
59 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1091
60 BLOOD PRESSURE INCREASED 1071
61 SEPSIS 1056
62 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1024
63 WEIGHT INCREASED 991
64 FREQUENT BOWEL MOVEMENTS 990
65 PERIPHERAL SWELLING 977
66 ACUTE KIDNEY INJURY 960
67 OEDEMA PERIPHERAL 911
68 SEIZURE 867
69 COVID-19 828
70 DRY MOUTH 823
71 DYSPEPSIA 812
72 PLATELET COUNT DECREASED 806
73 HOSPITALISATION 803
74 DRUG HYPERSENSITIVITY 782
75 HAEMOGLOBIN DECREASED 777
76 MUSCULAR WEAKNESS 773
77 NEUROPATHY PERIPHERAL 759
78 PRODUCT TASTE ABNORMAL 757
79 EXTRA DOSE ADMINISTERED 752
80 WHITE BLOOD CELL COUNT DECREASED 751
81 HYPOAESTHESIA 740
82 NASOPHARYNGITIS 732
83 DYSPHAGIA 721
84 RENAL FAILURE 715
85 HALLUCINATION 708
86 PULMONARY EMBOLISM 708
87 ERYTHEMA 705
88 DRUG PRESCRIBING ERROR 696
89 DISEASE PROGRESSION 687
90 GASTROOESOPHAGEAL REFLUX DISEASE 678
91 HYPONATRAEMIA 674
92 INFECTION 673
93 ATRIAL FIBRILLATION 668
94 DRUG EFFECT DECREASED 667
95 BALANCE DISORDER 665
96 THROMBOCYTOPENIA 665
97 DYSGEUSIA 655
98 MEMORY IMPAIRMENT 654
99 GENERAL PHYSICAL HEALTH DETERIORATION 650
100 HYPERSENSITIVITY 650
101 CHILLS 643
102 MYALGIA 637
103 SINUSITIS 637
104 HYPERHIDROSIS 630
105 FEBRILE NEUTROPENIA 610
106 GASTROINTESTINAL DISORDER 608
107 PARAESTHESIA 607
108 ALOPECIA 597
109 NEUTROPENIA 597
110 CHRONIC KIDNEY DISEASE 591
111 ABNORMAL FAECES 587
112 CONTUSION 585
113 LOSS OF CONSCIOUSNESS 578
114 URTICARIA 571
115 PLEURAL EFFUSION 567
116 SWELLING 565
117 CEREBROVASCULAR ACCIDENT 564
118 DRUG INTOLERANCE 558
119 BLOOD GLUCOSE INCREASED 553
120 STRESS 551
121 VISION BLURRED 543
122 MALIGNANT NEOPLASM PROGRESSION 542
123 HEART RATE INCREASED 536
124 INFLUENZA 533
125 PRODUCT QUALITY ISSUE 533
126 SLEEP DISORDER 526
127 SYNCOPE 522
128 FAECES DISCOLOURED 515
129 CARDIAC FAILURE CONGESTIVE 513
130 THROMBOSIS 513
131 GASTROINTESTINAL HAEMORRHAGE 511
132 DEEP VEIN THROMBOSIS 508
133 ILLNESS 507
134 DYSPHONIA 503
135 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 503
136 RECTAL HAEMORRHAGE 502
137 AGGRESSION 501
138 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 501
139 UNEVALUABLE EVENT 500
140 RESPIRATORY FAILURE 498
141 OROPHARYNGEAL PAIN 493
142 INTENTIONAL PRODUCT USE ISSUE 483
143 HAEMATOCHEZIA 479
144 INTENTIONAL PRODUCT MISUSE 472
145 PALPITATIONS 471
146 PRODUCT ODOUR ABNORMAL 467
147 INAPPROPRIATE PRESCRIBING 466
148 BLOOD CREATININE INCREASED 462
149 EPISTAXIS 458
150 DRY SKIN 455
151 JOINT SWELLING 454
152 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 450
153 DRUG DOSE OMISSION 442
154 INTESTINAL OBSTRUCTION 442
155 TACHYCARDIA 435
156 CHEST DISCOMFORT 434
157 LETHARGY 430
158 MIGRAINE 430
159 ABNORMAL BEHAVIOUR 426
160 STOMATITIS 425
161 ASCITES 422
162 ASTHMA 415
163 BRONCHITIS 415
164 MUSCULOSKELETAL STIFFNESS 415
165 NO ADVERSE EVENT 415
166 ANGER 408
167 CELLULITIS 402
168 HOT FLUSH 402
169 THERAPEUTIC RESPONSE UNEXPECTED 397
170 POLLAKIURIA 393
171 RHINORRHOEA 390
172 VISUAL IMPAIRMENT 389
173 PRODUCTIVE COUGH 385
174 AGITATION 384
175 BLOOD PRESSURE DECREASED 384
176 UPPER RESPIRATORY TRACT INFECTION 379
177 DIABETES MELLITUS 377
178 NECK PAIN 377
179 ADVERSE DRUG REACTION 373
180 DRUG INTERACTION 373
181 OXYGEN SATURATION DECREASED 372
182 ARTHRITIS 370
183 HYPOKALAEMIA 368
184 HYPOXIA 363
185 CARDIAC ARREST 362
186 FAECES SOFT 362
187 INJECTION SITE PAIN 361
188 DISCOMFORT 359
189 MYOCARDIAL INFARCTION 359
190 SWELLING FACE 356
191 BONE PAIN 354
192 PANCYTOPENIA 354
193 SPEECH DISORDER 352
194 THERAPEUTIC PRODUCT EFFECT DECREASED 350
195 BOWEL MOVEMENT IRREGULARITY 348
196 NEURALGIA 347
197 ASPARTATE AMINOTRANSFERASE INCREASED 346
198 HAEMORRHAGE 346
199 MENTAL STATUS CHANGES 341
200 END STAGE RENAL DISEASE 336
201 DYSURIA 335
202 BLOOD POTASSIUM DECREASED 334
203 BURNING SENSATION 334
204 FLUID RETENTION 328
205 BLOOD CHOLESTEROL INCREASED 325
206 FLUSHING 324
207 URINARY RETENTION 324
208 INJURY 320
209 MOBILITY DECREASED 318
210 DRUG DEPENDENCE 313
211 OEDEMA 313
212 ADVERSE EVENT 309
213 FAECES HARD 307
214 GASTROINTESTINAL MOTILITY DISORDER 307
215 AMNESIA 305
216 ANAL INCONTINENCE 305
217 CARDIAC DISORDER 302
218 COLITIS 301
219 HAEMORRHOIDS 299
220 INFUSION RELATED REACTION 299
221 IRRITABILITY 299
222 DYSKINESIA 298
223 NASAL CONGESTION 298
224 HEPATIC ENZYME INCREASED 296
225 HYPOPHAGIA 295
226 MULTIPLE ORGAN DYSFUNCTION SYNDROME 295
227 ALANINE AMINOTRANSFERASE INCREASED 294
228 ACUTE RESPIRATORY FAILURE 290
229 DRUG EFFECT DELAYED 290
230 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 290
231 POOR QUALITY DRUG ADMINISTERED 290
232 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 283
233 SWOLLEN TONGUE 283
234 WHEEZING 283
235 PRODUCT SOLUBILITY ABNORMAL 281
236 RED BLOOD CELL COUNT DECREASED 281
237 URINARY INCONTINENCE 279
238 NEPHROLITHIASIS 277
239 PARKINSON^S DISEASE 276
240 RETCHING 276
241 CATARACT 274
242 EMOTIONAL DISTRESS 272
243 GASTRIC DISORDER 270
244 MUSCULOSKELETAL PAIN 270
245 NERVOUSNESS 270
246 DYSPNOEA EXERTIONAL 269
247 PLASMA CELL MYELOMA 269
248 CARDIOGENIC SHOCK 268
249 HIP FRACTURE 268
250 PRESCRIBED UNDERDOSE 267
251 BLOOD SODIUM DECREASED 264
252 RENAL IMPAIRMENT 264
253 THERAPY INTERRUPTED 264
254 BACTERIAL INFECTION 261
255 APPENDICITIS 260
256 RENAL FAILURE ACUTE 259
257 VERTIGO 258
258 CONVULSION 257
259 RENAL DISORDER 257
260 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 256
261 OSTEOARTHRITIS 253
262 STAPHYLOCOCCAL INFECTION 252
263 EYE PAIN 250
264 INFLUENZA LIKE ILLNESS 250
265 NEUTROPHIL COUNT DECREASED 250
266 PNEUMONIA ASPIRATION 250
267 PULMONARY OEDEMA 249
268 SURGERY 249
269 PRODUCT PRESCRIBING ERROR 246
270 VENTRICULAR FIBRILLATION 246
271 HAEMOPTYSIS 244
272 RASH PRURITIC 243
273 DYSARTHRIA 242
274 HERPES ZOSTER 242
275 SUICIDAL IDEATION 242
276 THROAT IRRITATION 242
277 SKIN EXFOLIATION 241
278 CYSTITIS 240
279 COGNITIVE DISORDER 238
280 WHITE BLOOD CELL COUNT INCREASED 236
281 POOR QUALITY PRODUCT ADMINISTERED 234
282 DEVICE ISSUE 233
283 DRY EYE 232
284 GASTRITIS 232
285 HAEMATOCRIT DECREASED 232
286 HOSPICE CARE 232
287 INCORRECT DOSAGE ADMINISTERED 232
288 HYPERLIPIDAEMIA 230
289 LUNG DISORDER 230
290 PRODUCT DOSE OMISSION 230
291 TREATMENT NONCOMPLIANCE 229
292 VIRAL INFECTION 229
293 HYPERSOMNIA 226
294 MENTAL DISORDER 226
295 PANCREATITIS 226
296 SKIN DISCOLOURATION 226
297 FEELING HOT 225
298 PRESCRIBED OVERDOSE 225
299 CROHN^S DISEASE 223
300 CRYING 222
301 ORAL PAIN 222
302 APPENDICOLITH 221
303 HEAD INJURY 221
304 RESPIRATORY DISTRESS 221
305 TRANSIENT ISCHAEMIC ATTACK 221
306 MULTIPLE SCLEROSIS RELAPSE 220
307 SMALL INTESTINAL OBSTRUCTION 218
308 DIVERTICULITIS 216
309 MACULAR DEGENERATION 213
310 SEPTIC SHOCK 213
311 BLISTER 212
312 PRODUCT LABEL CONFUSION 212
313 DRUG ADMINISTRATION ERROR 211
314 BRADYCARDIA 210
315 CARDIAC FAILURE 209
316 CORONARY ARTERY DISEASE 209
317 UNRESPONSIVE TO STIMULI 209
318 BLOOD PHOSPHORUS INCREASED 208
319 CHOLELITHIASIS 208
320 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 208
321 HEART RATE DECREASED 207
322 OSTEOPOROSIS 207
323 PROCEDURAL PAIN 207
324 ATELECTASIS 206
325 MOOD SWINGS 205
326 NIGHT SWEATS 205
327 PRODUCT USE COMPLAINT 205
328 ABDOMINAL PAIN LOWER 204
329 GOUT 204
330 HYPOPHOSPHATAEMIA 203
331 DEPRESSED MOOD 202
332 DRUG EFFECT INCOMPLETE 200
333 GAIT INABILITY 200
334 IMPAIRED GASTRIC EMPTYING 200
335 DISTURBANCE IN ATTENTION 199
336 ARTHROPATHY 197
337 DEMENTIA 197
338 IRRITABLE BOWEL SYNDROME 197
339 MICTURITION URGENCY 197
340 FEELING COLD 195
341 THERAPY CESSATION 195
342 TINNITUS 195
343 HALLUCINATION, VISUAL 194
344 HYPERKALAEMIA 193
345 DYSSTASIA 191
346 TOXICITY TO VARIOUS AGENTS 189
347 DISORIENTATION 188
348 EAR INFECTION 188
349 FAECAL INCONTINENCE 187
350 FAECALOMA 187
351 WRONG TECHNIQUE IN DRUG USAGE PROCESS 187
352 HAEMATURIA 186
353 CARDIO-RESPIRATORY ARREST 185
354 FULL BLOOD COUNT DECREASED 185
355 HYPERPHOSPHATAEMIA 185
356 SLEEP APNOEA SYNDROME 185
357 EXPIRED DRUG ADMINISTERED 184
358 INTERNATIONAL NORMALISED RATIO INCREASED 184
359 PRODUCT PHYSICAL ISSUE 184
360 THERAPEUTIC RESPONSE DECREASED 183
361 NOCTURIA 182
362 ULCER 182
363 INJECTION SITE ERYTHEMA 181
364 MYASTHENIA GRAVIS 181
365 DRUG EFFECT LESS THAN EXPECTED 180
366 DRUG WITHDRAWAL SYNDROME 180
367 ENCEPHALOPATHY 180
368 EATING DISORDER 179
369 PAIN IN JAW 179
370 HYPERGLYCAEMIA 178
371 BLOOD ALKALINE PHOSPHATASE INCREASED 177
372 FUNGAL INFECTION 177
373 PRESYNCOPE 177
374 BLOOD POTASSIUM INCREASED 176
375 GASTROINTESTINAL PAIN 176
376 TASTE DISORDER 176
377 ANAPHYLACTIC REACTION 175
378 LEUKOCYTOSIS 175
379 LYMPHADENOPATHY 175
380 ASPIRATION 173
381 HYPOTHYROIDISM 173
382 COLITIS ULCERATIVE 172
383 BLOOD GLUCOSE DECREASED 170
384 DELIRIUM 170
385 TIC 170
386 HYPOGLYCAEMIA 169
387 LABORATORY TEST ABNORMAL 169
388 LEUKOPENIA 169
389 SKIN ULCER 169
390 ARRHYTHMIA 168
391 BLOOD URIC ACID INCREASED 168
392 MALNUTRITION 168
393 RASH ERYTHEMATOUS 168
394 THERAPEUTIC PRODUCT EFFECT DELAYED 167
395 HYPOACUSIS 166
396 ILL-DEFINED DISORDER 166
397 IMPAIRED HEALING 166
398 PANIC ATTACK 166
399 PARAESTHESIA ORAL 166
400 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 166
401 CHROMATURIA 165
402 EYE IRRITATION 165
403 POOR QUALITY SLEEP 165
404 APHASIA 164
405 ERUCTATION 164
406 EMOTIONAL DISORDER 163
407 FIBROMYALGIA 163
408 NIGHTMARE 163
409 NEOPLASM MALIGNANT 162
410 JOINT INJURY 161
411 LIMB INJURY 161
412 ORAL CANDIDIASIS 161
413 ANGIOEDEMA 159
414 BLOOD PRESSURE FLUCTUATION 159
415 GASTROENTERITIS VIRAL 159
416 MOOD ALTERED 159
417 NEPHROGENIC ANAEMIA 159
418 ACNE 158
419 LIMB DISCOMFORT 157
420 MULTIPLE SCLEROSIS 155
421 NEOPLASM PROGRESSION 155
422 SKIN DISORDER 155
423 MUSCLE SPASTICITY 154
424 RIB FRACTURE 154
425 ROAD TRAFFIC ACCIDENT 154
426 TROPONIN INCREASED 154
427 DECUBITUS ULCER 153
428 ACCIDENTAL OVERDOSE 152
429 BLOOD TEST ABNORMAL 152
430 IRON DEFICIENCY 152
431 MOVEMENT DISORDER 152
432 MUSCULOSKELETAL CHEST PAIN 152
433 PNEUMONITIS 152
434 PRODUCT CONTAMINATION PHYSICAL 150
435 BLOOD CALCIUM INCREASED 149
436 ILEUS 148
437 CHOKING 147
438 THERAPY NON-RESPONDER 147
439 ELECTROCARDIOGRAM QT PROLONGED 146
440 BLOOD BILIRUBIN INCREASED 145
441 DIPLOPIA 145
442 INTERVERTEBRAL DISC PROTRUSION 145
443 PERICARDIAL EFFUSION 145
444 PULMONARY MASS 145
445 RESPIRATORY TRACT INFECTION 145
446 RESTLESSNESS 145
447 SINUS DISORDER 145
448 HIATUS HERNIA 143
449 PULMONARY HYPERTENSION 143
450 RASH MACULAR 143
451 UPPER GASTROINTESTINAL HAEMORRHAGE 143
452 CONTRAINDICATED PRODUCT ADMINISTERED 142
453 DELUSION 142
454 MATERNAL EXPOSURE DURING PREGNANCY 142
455 RHEUMATOID ARTHRITIS 142
456 INTENTIONAL DOSE OMISSION 141
457 MEDICATION ERROR 141
458 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 140
459 CHRONIC SINUSITIS 140
460 LIVER FUNCTION TEST INCREASED 140
461 LOWER RESPIRATORY TRACT INFECTION 140
462 LYMPHOCYTE COUNT DECREASED 140
463 CYTOKINE RELEASE SYNDROME 139
464 PROCTALGIA 139
465 DEFAECATION URGENCY 138
466 FEEDING DISORDER 138
467 INFREQUENT BOWEL MOVEMENTS 138
468 ORAL DISCOMFORT 138
469 CYSTIC FIBROSIS 137
470 PSORIASIS 137
471 GASTROINTESTINAL SOUNDS ABNORMAL 136
472 GLOSSODYNIA 136
473 PRODUCT SUBSTITUTION ISSUE 136
474 HERNIA 135
475 INFUSION SITE PAIN 135
476 OCULAR HYPERAEMIA 135
477 LIVER DISORDER 134
478 MIDDLE INSOMNIA 134
479 THERAPEUTIC PRODUCT EFFECT VARIABLE 134
480 BLOOD URINE PRESENT 133
481 DYSCHEZIA 133
482 SEASONAL ALLERGY 133
483 BLOOD PRESSURE ABNORMAL 132
484 FAILURE TO THRIVE 132
485 ORTHOSTATIC HYPOTENSION 132
486 SPINAL OSTEOARTHRITIS 132
487 ANHEDONIA 131
488 CLOSTRIDIUM DIFFICILE INFECTION 131
489 ECONOMIC PROBLEM 131
490 PARANOIA 131
491 RESPIRATORY DISORDER 131
492 ECZEMA 130
493 INJECTION SITE BRUISING 130
494 MUCOSAL INFLAMMATION 130
495 SEDATION 130
496 EYE SWELLING 129
497 SPINAL FRACTURE 128
498 BACTERAEMIA 127
499 BLOOD CALCIUM DECREASED 127
500 BLOOD UREA INCREASED 127
501 ANALGESIC THERAPY 126
502 FEAR 126
503 HAEMATEMESIS 126
504 PRODUCT DOSE OMISSION IN ERROR 126
505 EYE DISORDER 125
506 LIP SWELLING 125
507 LOCALISED INFECTION 125
508 TOOTH DISORDER 125
509 CANDIDA INFECTION 124
510 DEPRESSED LEVEL OF CONSCIOUSNESS 124
511 DEVICE DISLOCATION 124
512 OBSESSIVE-COMPULSIVE DISORDER 124
513 MUSCLE TWITCHING 123
514 OSTEOMYELITIS 123
515 SLEEP DISORDER THERAPY 123
516 MUSCLE TIGHTNESS 122
517 RENAL INJURY 122
518 LIVER FUNCTION TEST ABNORMAL 121
519 METABOLIC ACIDOSIS 121
520 NERVOUS SYSTEM DISORDER 121
521 WOUND 121
522 ACUTE MYOCARDIAL INFARCTION 120
523 OSTEOPENIA 120
524 PALLOR 120
525 AGEUSIA 119
526 HAEMATOMA 119
527 HEART RATE IRREGULAR 119
528 INFLAMMATION 119
529 LACRIMATION INCREASED 119
530 PNEUMOTHORAX 119
531 DRUG THERAPY 118
532 MITRAL VALVE INCOMPETENCE 118
533 TRANSAMINASES INCREASED 118
534 BRAIN FOG 116
535 DISEASE RECURRENCE 116
536 INTERVERTEBRAL DISC DEGENERATION 116
537 EAR PAIN 115
538 PSYCHOTIC DISORDER 115
539 SKIN LESION 115
540 TYPE 2 DIABETES MELLITUS 115
541 HYPERCALCAEMIA 114
542 FEMUR FRACTURE 113
543 FOOT FRACTURE 113
544 MUSCULOSKELETAL DISCOMFORT 113
545 OSTEONECROSIS OF JAW 113
546 RESTLESS LEGS SYNDROME 113
547 THINKING ABNORMAL 113
548 CARDIAC MURMUR 112
549 INCONTINENCE 112
550 CARDIOMEGALY 111
551 IRON DEFICIENCY ANAEMIA 111
552 AORTIC STENOSIS 110
553 HEPATIC STEATOSIS 110
554 KIDNEY INFECTION 110
555 GALLBLADDER DISORDER 109
556 THROAT TIGHTNESS 109
557 BLOOD ALBUMIN DECREASED 108
558 BLOOD PRESSURE SYSTOLIC INCREASED 108
559 ELECTROLYTE IMBALANCE 108
560 POST PROCEDURAL COMPLICATION 108
561 SINUS TACHYCARDIA 108
562 FEELING JITTERY 107
563 GASTROENTERITIS 107
564 BACK DISORDER 106
565 BONE DISORDER 106
566 CEREBRAL HAEMORRHAGE 106
567 DRUG ABUSE 106
568 RENAL FAILURE CHRONIC 106
569 THIRST 106
570 ANGINA PECTORIS 105
571 COAGULOPATHY 105
572 HEAD DISCOMFORT 105
573 METASTASES TO BONE 105
574 PRODUCT LABEL ISSUE 104
575 INCREASED APPETITE 103
576 INJECTION SITE SWELLING 103
577 TOOTHACHE 103
578 UPPER LIMB FRACTURE 103
579 WITHDRAWAL SYNDROME 103
580 BODY TEMPERATURE INCREASED 102
581 SECRETION DISCHARGE 102
582 FLANK PAIN 101
583 RADICULOPATHY 101
584 SCIATICA 101
585 COMA 100
586 DIVERTICULUM 100
587 EYE PRURITUS 100
588 GASTRIC ULCER 100
589 INJECTION SITE PRURITUS 100
590 TREATMENT FAILURE 100
591 BREATH SOUNDS ABNORMAL 99
592 FULL BLOOD COUNT ABNORMAL 99
593 INFUSION SITE ERYTHEMA 99
594 MOUTH ULCERATION 99
595 OBESITY 99
596 RESPIRATORY TRACT CONGESTION 99
597 HYPOCALCAEMIA 98
598 INSURANCE ISSUE 98
599 JOINT STIFFNESS 98
600 MENTAL IMPAIRMENT 98
601 PULMONARY FIBROSIS 98
602 RHINOVIRUS INFECTION 98
603 SCREAMING 98
604 VAGINAL DISCHARGE 98
605 DEVICE RELATED INFECTION 97
606 DIZZINESS POSTURAL 97
607 FLUID OVERLOAD 97
608 ISCHAEMIC STROKE 97
609 RASH PAPULAR 97
610 TENDERNESS 97
611 BLOOD COUNT ABNORMAL 96
612 DEVICE OCCLUSION 96
613 INTERCEPTED DRUG PRESCRIBING ERROR 96
614 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 96
615 SPUTUM DISCOLOURED 96
616 WEIGHT FLUCTUATION 96
617 ABNORMAL DREAMS 95
618 ANORECTAL DISCOMFORT 95
619 BENIGN PROSTATIC HYPERPLASIA 95
620 BRONCHIECTASIS 95
621 HEMIPARESIS 95
622 METASTASES TO LIVER 95
623 PRODUCT ADMINISTRATION INTERRUPTED 95
624 VAGINAL HAEMORRHAGE 95
625 ACCIDENTAL EXPOSURE TO PRODUCT 94
626 DENTAL CARIES 94
627 BLADDER DISORDER 93
628 BLOOD MAGNESIUM DECREASED 93
629 LOWER LIMB FRACTURE 93
630 PSEUDOMONAS INFECTION 93
631 SKIN CANCER 93
632 TUBULOINTERSTITIAL NEPHRITIS 93
633 BLOOD IRON DECREASED 92
634 BODY HEIGHT DECREASED 92
635 CLOSTRIDIUM DIFFICILE COLITIS 92
636 DEAFNESS 92
637 DEVICE MALFUNCTION 92
638 LOCAL SWELLING 92
639 PULMONARY CONGESTION 92
640 ABASIA 91
641 HEPATIC FAILURE 91
642 INJECTION SITE HAEMORRHAGE 91
643 OESOPHAGITIS 91
644 PANCREATITIS ACUTE 91
645 PROCTITIS 91
646 PROSTATIC SPECIFIC ANTIGEN INCREASED 91
647 SICKLE CELL ANAEMIA WITH CRISIS 91
648 PRODUCT ADMINISTRATION ERROR 90
649 PRODUCT PHYSICAL CONSISTENCY ISSUE 90
650 ON AND OFF PHENOMENON 89
651 RESPIRATORY SYNCYTIAL VIRUS INFECTION 89
652 RHABDOMYOLYSIS 89
653 THERAPEUTIC RESPONSE SHORTENED 89
654 VITAMIN D DEFICIENCY 89
655 CARPAL TUNNEL SYNDROME 88
656 GAMMA-GLUTAMYLTRANSFERASE INCREASED 88
657 TRANSFUSION 88
658 TRICUSPID VALVE INCOMPETENCE 88
659 URINE OUTPUT DECREASED 88
660 UROSEPSIS 88
661 BLINDNESS 87
662 BLOOD CREATINE PHOSPHOKINASE INCREASED 87
663 RASH MACULO-PAPULAR 87
664 DECREASED ACTIVITY 86
665 HYPERCHOLESTEROLAEMIA 86
666 PLATELET COUNT INCREASED 86
667 SPINAL COMPRESSION FRACTURE 86
668 ACTIVITIES OF DAILY LIVING IMPAIRED 85
669 SINUS CONGESTION 85
670 BREAST CANCER 84
671 FRUSTRATION TOLERANCE DECREASED 84
672 HEPATIC CYTOLYSIS 84
673 HYDRONEPHROSIS 84
674 JAUNDICE 84
675 MELAENA 84
676 ANTACID THERAPY 83
677 ANTICOAGULANT THERAPY 83
678 DROOLING 83
679 FEMALE GENITAL TRACT FISTULA 83
680 HAEMORRHOIDAL HAEMORRHAGE 83
681 KNEE ARTHROPLASTY 83
682 LUNG INFECTION 83
683 RENAL TUBULAR NECROSIS 83
684 SCOLIOSIS 83
685 SUSPECTED OFF LABEL USE 83
686 CHOLECYSTITIS 82
687 LOWER GASTROINTESTINAL HAEMORRHAGE 82
688 LUNG NEOPLASM MALIGNANT 82
689 PRE-EXISTING CONDITION IMPROVED 82
690 RASH GENERALISED 82
691 DERMATITIS CONTACT 81
692 HYPOKINESIA 81
693 HYPOMAGNESAEMIA 81
694 PRODUCT STORAGE ERROR 81
695 PRURITUS GENERALISED 81
696 RESPIRATORY ARREST 81
697 SNEEZING 81
698 ATAXIA 80
699 C-REACTIVE PROTEIN INCREASED 80
700 COLD SWEAT 80
701 GENERALISED OEDEMA 80
702 HYPERPARATHYROIDISM SECONDARY 80
703 HYPOAESTHESIA ORAL 80
704 INFUSION SITE SWELLING 80
705 LACTIC ACIDOSIS 80
706 ORAL HERPES 80
707 PHARMACEUTICAL PRODUCT COMPLAINT 80
708 SUBDURAL HAEMATOMA 80
709 INJECTION SITE REACTION 79
710 BEHAVIOUR DISORDER 78
711 INTERSTITIAL LUNG DISEASE 78
712 SKIN INFECTION 78
713 THYROID DISORDER 78
714 CARDIOMYOPATHY 77
715 COMPRESSION FRACTURE 77
716 EXPOSURE DURING PREGNANCY 77
717 GENERALISED TONIC-CLONIC SEIZURE 77
718 GINGIVAL PAIN 77
719 HAEMORRHAGIC ANAEMIA 77
720 PHOTOPHOBIA 76
721 BLOOD TRIGLYCERIDES INCREASED 75
722 BURSITIS 75
723 INCREASED TENDENCY TO BRUISE 75
724 PERITONITIS 75
725 RHINITIS 75
726 SENSORY DISTURBANCE 75
727 SYSTEMIC LUPUS ERYTHEMATOSUS 75
728 DRUG EFFECT INCREASED 74
729 GLOMERULAR FILTRATION RATE DECREASED 74
730 SCAR 74
731 SKIN BURNING SENSATION 74
732 ABSCESS 73
733 CARBOHYDRATE ANTIGEN 125 INCREASED 73
734 COMPLICATION ASSOCIATED WITH DEVICE 73
735 MULTIPLE ALLERGIES 73
736 PERIPHERAL COLDNESS 73
737 PHOTOSENSITIVITY REACTION 73
738 PLEURITIC PAIN 73
739 PNEUMONIA BACTERIAL 73
740 RALES 73
741 ROTATOR CUFF SYNDROME 73
742 SUICIDE ATTEMPT 73
743 INITIAL INSOMNIA 72
744 MASS 72
745 SKIN LACERATION 72
746 COLITIS ISCHAEMIC 71
747 COORDINATION ABNORMAL 71
748 GINGIVAL BLEEDING 71
749 MUSCLE RIGIDITY 71
750 ARTERIOSCLEROSIS 70
751 DRY THROAT 70
752 IMPAIRED WORK ABILITY 70
753 PELVIC PAIN 70
754 PRODUCT PREPARATION ISSUE 70
755 PSYCHOMOTOR HYPERACTIVITY 70
756 UPPER-AIRWAY COUGH SYNDROME 70
757 VAGINAL FLATULENCE 70
758 HYPOALBUMINAEMIA 69
759 HYPOTONIA 69
760 IMMUNODEFICIENCY 69
761 MUSCLE ATROPHY 69
762 RENAL CYST 69
763 SKIN IRRITATION 69
764 TOOTH INFECTION 69
765 ANKLE FRACTURE 68
766 CONJUNCTIVITIS 68
767 DIVERTICULUM INTESTINAL 68
768 EOSINOPHILIA 68
769 NEPHROPATHY 68
770 TARDIVE DYSKINESIA 68
771 TOOTH LOSS 67
772 ACUTE RESPIRATORY DISTRESS SYNDROME 66
773 BLOOD GLUCOSE ABNORMAL 66
774 DERMATITIS 66
775 DEVICE LEAKAGE 66
776 DYSTONIA 66
777 EPILEPSY 66
778 GROIN PAIN 66
779 HEPATIC CIRRHOSIS 66
780 INTESTINAL PERFORATION 66
781 LUNG INFILTRATION 66
782 NERVE COMPRESSION 66
783 NEUROTOXICITY 66
784 TEMPERATURE INTOLERANCE 66
785 VISUAL ACUITY REDUCED 66
786 ATRIAL FLUTTER 65
787 CARDIOVASCULAR DISORDER 65
788 HEPATITIS 65
789 HYPOVOLAEMIA 65
790 IMPAIRED QUALITY OF LIFE 65
791 INJECTION SITE MASS 65
792 LIGAMENT SPRAIN 65
793 PETECHIAE 65
794 PHARYNGEAL OEDEMA 65
795 SPLENOMEGALY 65
796 ACUTE MYELOID LEUKAEMIA 64
797 BEDRIDDEN 64
798 DEVICE BREAKAGE 64
799 PHARYNGITIS STREPTOCOCCAL 64
800 PRODUCT PACKAGING DIFFICULT TO OPEN 64
801 PRODUCT PACKAGING ISSUE 64
802 PROSTATE CANCER 64
803 PULMONARY ARTERIAL HYPERTENSION 64
804 SKIN ABRASION 64
805 SPINAL OPERATION 64
806 TOOTH FRACTURE 64
807 ALTERED STATE OF CONSCIOUSNESS 63
808 BONE MARROW FAILURE 63
809 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 63
810 GLAUCOMA 63
811 HIP ARTHROPLASTY 63
812 LYMPHOEDEMA 63
813 PAROSMIA 63
814 SALIVARY HYPERSECRETION 63
815 BASAL CELL CARCINOMA 62
816 HUNGER 62
817 JOINT DISLOCATION 62
818 MUSCULOSKELETAL DISORDER 62
819 NO THERAPEUTIC RESPONSE 62
820 PRODUCT DISTRIBUTION ISSUE 62
821 PROTEINURIA 62
822 PULMONARY FUNCTION TEST DECREASED 62
823 TOOTH ABSCESS 62
824 VENTRICULAR TACHYCARDIA 62
825 BONE DENSITY DECREASED 61
826 CHOLECYSTECTOMY 61
827 CONGENITAL HIATUS HERNIA 61
828 DYSPHEMIA 61
829 MANIA 61
830 PELVIC FRACTURE 61
831 TACHYPNOEA 61
832 URINE ODOUR ABNORMAL 61
833 WOUND INFECTION 61
834 ADRENAL INSUFFICIENCY 60
835 DIALYSIS 60
836 HAIR COLOUR CHANGES 60
837 HICCUPS 60
838 INTERCEPTED MEDICATION ERROR 60
839 NERVE INJURY 60
840 ONYCHOCLASIS 60
841 PAIN OF SKIN 60
842 PRODUCT PACKAGE ASSOCIATED INJURY 60
843 EMPHYSEMA 59
844 EXTRAPYRAMIDAL DISORDER 59
845 EYE INFECTION 59
846 FACIAL PARALYSIS 59
847 FREEZING PHENOMENON 59
848 INTENTIONAL SELF-INJURY 59
849 NEUROGENIC BLADDER 59
850 SLEEP TERROR 59
851 THERAPEUTIC PRODUCT INEFFECTIVE 59
852 ADVERSE REACTION 58
853 EJECTION FRACTION DECREASED 58
854 ESSENTIAL HYPERTENSION 58
855 GLYCOSYLATED HAEMOGLOBIN INCREASED 58
856 LEFT VENTRICULAR HYPERTROPHY 58
857 MUSCLE STRAIN 58
858 OBSTRUCTIVE AIRWAYS DISORDER 58
859 OSTEONECROSIS 58
860 VENTRICULAR EXTRASYSTOLES 58
861 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 57
862 BRONCHOSPASM 57
863 CENTRAL NERVOUS SYSTEM LESION 57
864 ECCHYMOSIS 57
865 HAEMORRHAGE INTRACRANIAL 57
866 INCORRECT ROUTE OF DRUG ADMINISTRATION 57
867 METASTASES TO LUNG 57
868 PERSONALITY CHANGE 57
869 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 56
870 CYST 56
871 DECREASED INTEREST 56
872 DEVICE FAILURE 56
873 DRUG LEVEL INCREASED 56
874 ESCHERICHIA INFECTION 56
875 FOETAL EXPOSURE DURING PREGNANCY 56
876 HEREDITARY ANGIOEDEMA 56
877 INTENTIONAL OVERDOSE 56
878 OCULAR DISCOMFORT 56
879 PERITONITIS BACTERIAL 56
880 SLUGGISHNESS 56
881 SUPRAVENTRICULAR TACHYCARDIA 56
882 VITAMIN D DECREASED 56
883 WALKING AID USER 56
884 ABDOMINAL TENDERNESS 55
885 AFFECTIVE DISORDER 55
886 ANOREXIA 55
887 CEREBRAL ATROPHY 55
888 CHANGE OF BOWEL HABIT 55
889 HALLUCINATION, AUDITORY 55
890 HYPOPNOEA 55
891 PHARYNGITIS 55
892 POST PROCEDURAL INFECTION 55
893 SHOCK 55
894 COLON CANCER 54
895 CYTOPENIA 54
896 EAR DISCOMFORT 54
897 EXOSTOSIS 54
898 HYPERBILIRUBINAEMIA 54
899 LACERATION 54
900 LARGE INTESTINE PERFORATION 54
901 LUNG OPACITY 54
902 MULTIPLE MYELOMA 54
903 PARALYSIS 54
904 PERIPHERAL VASCULAR DISORDER 54
905 PERONEAL NERVE PALSY 54
906 PROTHROMBIN TIME PROLONGED 54
907 RESPIRATORY SYMPTOM 54
908 SNORING 54
909 SPINAL CORD COMPRESSION 54
910 SPINAL DISORDER 54
911 CEREBRAL INFARCTION 53
912 FOOT DEFORMITY 53
913 FRACTURE 53
914 FUNCTIONAL GASTROINTESTINAL DISORDER 53
915 MYELODYSPLASTIC SYNDROME 53
916 MYOCARDIAL ISCHAEMIA 53
917 NODULE 53
918 NON-CARDIAC CHEST PAIN 53
919 PRODUCT PACKAGING QUANTITY ISSUE 53
920 RED CELL DISTRIBUTION WIDTH INCREASED 53
921 RENAL PAIN 53
922 TOOTH EXTRACTION 53
923 BRAIN OEDEMA 52
924 HEPATOMEGALY 52
925 HYPERVOLAEMIA 52
926 INCORRECT DRUG ADMINISTRATION RATE 52
927 LARGE INTESTINE POLYP 52
928 NEEDLE ISSUE 52
929 ORAL MUCOSAL BLISTERING 52
930 PANCREATIC CARCINOMA 52
931 PROTEIN TOTAL DECREASED 52
932 SKIN HAEMORRHAGE 52
933 SPINAL COLUMN STENOSIS 52
934 ARTERIOSCLEROSIS CORONARY ARTERY 51
935 BIPOLAR DISORDER 51
936 BODY TEMPERATURE DECREASED 51
937 BONE LESION 51
938 CHOLECYSTITIS CHRONIC 51
939 DISABILITY 51
940 ESCHERICHIA URINARY TRACT INFECTION 51
941 EYE MOVEMENT DISORDER 51
942 GASTROINTESTINAL INFECTION 51
943 INTENTIONAL UNDERDOSE 51
944 MALIGNANT MELANOMA 51
945 METASTASES TO CENTRAL NERVOUS SYSTEM 51
946 NASAL DRYNESS 51
947 POLYP 51
948 RESPIRATORY RATE INCREASED 51
949 SKIN FISSURES 51
950 TOTAL LUNG CAPACITY DECREASED 51
951 WRIST FRACTURE 51
952 ANAL FISSURE 50
953 CEREBRAL HYPOPERFUSION 50
954 COVID-19 PNEUMONIA 50
955 FACIAL PAIN 50
956 FAECAL VOLUME DECREASED 50
957 LARYNGITIS 50
958 OROPHARYNGEAL DISCOMFORT 50
959 PRODUCT DISPENSING ERROR 50
960 VASCULAR DEVICE INFECTION 50
961 AGRANULOCYTOSIS 49
962 APPETITE DISORDER 49
963 BLOOD THYROID STIMULATING HORMONE INCREASED 49
964 BREAST PAIN 49
965 CHOLESTASIS 49
966 DRUG-INDUCED LIVER INJURY 49
967 EPIGASTRIC DISCOMFORT 49
968 EYE DISCHARGE 49
969 HAEMOGLOBIN ABNORMAL 49
970 HEPATIC LESION 49
971 MAJOR DEPRESSION 49
972 MUSCLE DISORDER 49
973 NEUTROPHIL COUNT INCREASED 49
974 POSTURE ABNORMAL 49
975 PYELONEPHRITIS 49
976 RESPIRATORY DEPRESSION 49
977 SCAB 49
978 TONGUE DISORDER 49
979 ABDOMINAL HERNIA 48
980 CONCUSSION 48
981 HAIR TEXTURE ABNORMAL 48
982 MALIGNANT MELANOMA STAGE 0 48
983 APHONIA 47
984 DRUG LEVEL DECREASED 47
985 EXPOSURE TO UNSPECIFIED AGENT 47
986 HYPERTONIA 47
987 INFUSION SITE EXTRAVASATION 47
988 LUNG CONSOLIDATION 47
989 LYMPHOPENIA 47
990 POST PROCEDURAL HAEMORRHAGE 47
991 POSTOPERATIVE WOUND INFECTION 47
992 SOCIAL AVOIDANT BEHAVIOUR 47
993 STATUS EPILEPTICUS 47
994 ACIDOSIS 46
995 AORTIC ANEURYSM 46
996 APPLICATION SITE ERYTHEMA 46
997 HEMIPLEGIA 46
998 HYPERTHYROIDISM 46
999 IMMUNE SYSTEM DISORDER 46